Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DANSHU Capsule (Menthol) for Prehypertension and Mild Hypertension
NCT01408446Phase 3Completed
- Start
- Aug 2012
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in prehypertension and hypertension (HTN) comparing Menthol with Placebo (2 arms). Primary endpoint: Decrease in diastolic blood pressure at 8 weeks. Started Aug 2012; status: completed.
02
Drugs
l-Menthol
03
Conditions
prehypertensionhypertension (HTN)
Beyond the preview
Go deeper on NCT01408446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01408446.